Cancer-related mortality in Peru: Trends from 2003 to 2016

被引:20
|
作者
Zafra-Tanaka, Jessica H. [1 ]
Tenorio-Mucha, Janeth [1 ]
Villarreal-Zegarra, David [1 ]
Carrillo-Larco, Rodrigo [1 ,2 ,3 ]
Bernabe-Ortiz, Antonio [1 ,4 ]
机构
[1] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru
[2] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England
[3] Univ Catolica Los Angeles Chimbote ULADECH, Ctr Estudios Poblac, Chimbote, Peru
[4] Univ Cient Sur, Lima, Peru
来源
PLOS ONE | 2020年 / 15卷 / 02期
基金
英国惠康基金;
关键词
LUNG-CANCER; SURVIVAL; RESISTANCE; RATES;
D O I
10.1371/journal.pone.0228867
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives In the last decade, Latin American (LA) countries, like Peru, have undergone an epidemiological transition that has changed the pattern of oncological cases. Given that Peru's oncological pattern could illustrate those of other LA countries, we aimed at determining trends and changes in cancer-related mortality by age and sex in Peru between 2003 and 2016. Methods and results A secondary data analysis using national deaths registries was conducted. Categories were created according to the 27 most frequent sites of presentation of cancer. We found that deaths attributed to cancer increased from 15.4% of all deaths in 2003 to 18.1% in 2016 (p<0.001). According to the cancer site, stomach cancer (19.1%) and lung cancer (11.5%) were the most frequent causes of death overall. In childhood (0 to 14 years), the two most frequent fatal cancers were leukemia (54.6% for boys and 53.5% for girls) and brain and nervous system tumors (19.4% for boys and 20.3% for girls). For teenagers and young male adults (15-49 years), stomach cancer (18.1%) and brain cancer (17.4%) were the leading causes of death; in their female counterparts, cervix uteri (20.0%) and breast cancer (16.1%) were the most mortal cancers. In adults (>= 50 years), stomach (20.9% for men and 18.6% for women) and lung (12.7% for men and 10.4% for women) were the leading contributors to the burden of cancer deaths. Conclusions Between the years 2003 and 2016, almost one fifth of deaths were attributed to cancer in Peru. Absolute and relative number of deaths due to cancer has increased in this period for both men and women; however, standardized mortality rates due to cancer have declined.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Cancer-Related Mortality in People With Mental Illness
    Kisely, Stephen
    Crowe, Elizabeth
    Lawrence, David
    JAMA PSYCHIATRY, 2013, 70 (02) : 209 - 217
  • [22] Spermidine reduces cancer-related mortality in humans
    Pietrocola, Federico
    Castoldi, Francesca
    Kepp, Oliver
    Carmona-Gutierrez, Didac
    Madeo, Frank
    Kroemer, Guido
    AUTOPHAGY, 2019, 15 (02) : 362 - 365
  • [23] Insulin resistance and cancer-related mortality - Reply
    Yun, Young Ho
    Park, Sang Min
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1629 - 1630
  • [24] Statins and Cancer-Related Mortality: An Open Question
    Gazzerro, Patrizia
    Ciaglia, Elena
    Bifulco, Maurizio
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 73 - 74
  • [25] Trends in early onset colorectal cancer-related mortality among adults in the United States from 1999-2020.
    Zafar, Yousaf
    Zafar, Adnan
    Iqbal, Arsalan Zafar
    Rizwan, Marryum
    Manzoor, Laila
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 42 - 42
  • [26] IMPACT OF COMPETING MORTALITY ON THE CANCER-RELATED MORTALITY IN LOCALIZED PROSTATE-CANCER
    AUS, G
    PILEBLAD, E
    HUGOSSON, J
    UROLOGY, 1995, 46 (05) : 672 - 675
  • [27] OBESITY AND DIABETES: THE INCREASED RISK OF CANCER AND CANCER-RELATED MORTALITY
    Gallagher, Emily Jane
    LeRoith, Derek
    PHYSIOLOGICAL REVIEWS, 2015, 95 (03) : 727 - 748
  • [28] Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy
    Zorzi, Manuel
    Dal Maso, Luigino
    Francisci, Silvia
    Buzzoni, Carlotta
    Rugge, Massimo
    Guzzinati, Stefano
    Mazzoleni, G.
    Coviello, E.
    Galasso, R.
    Sampietro, G.
    Magoni, M.
    Ardizzone, A.
    D'Argenzio, A.
    Sardo, A. Sutera
    Giorno, A.
    La Greca, G.
    Ricci, P.
    Ferretti, S.
    Palma, F.
    Serraino, D.
    Iacovacci, S.
    Melcarne, A.
    Puppo, A.
    Sciacca, S.
    Russo, A. G.
    Caruso, B.
    d'Oro, L. Cavalieri
    D'Orsi, G.
    Fusco, M.
    Usala, M.
    Vitale, F.
    Cusimano, R.
    Michiara, M.
    Boschetti, L.
    Chiaranda, G.
    Rosso, S.
    Tumino, R.
    Mangone, L.
    Falcini, F.
    Caiazzo, A. L.
    Cesaraccio, R.
    Tisano, F.
    Fanetti, A. C.
    Minerba, S.
    Caldarella, A.
    Candela, G.
    Piffer, S.
    Cania, A.
    Castelli, M.
    Pisani, M.
    TUMORI JOURNAL, 2019, 105 (05): : 417 - 426
  • [30] Statintherapie und KarzinomsterblichkeitStatin therapy and cancer-related mortality
    E. Windler
    S. Nitschmann
    Der Internist, 2013, 54 (9): : 1152 - 1154